UK-based drug discovery organisation Concept Life Sciences (CLS), backed by mid-market private equity investment firm Limerston Capital, has completed the acquisition of Charnwood Discovery.
VALANX Biotech and FinaBio sign joint licensing agreement to commercialise ready-to-conjugate vaccine carrier protein CRM197 will enable rapid development of conjugate vaccines.
This week’s budget saw several major announcements for the UK life sciences sector. Yogan Patel, head of life sciences for MHA, the UK member firm of the global Baker Tilly network, explores what’s been announced and what it means for the industry.
Sterling Pharma Solutions, announced the second phase of an expansion strategy at its Deeside, UK site to support antibody-drug conjugate (ADC) development, with a more than £10 million investment to increase GMP bioconjugation capacity.
ProductLife Group (PLG) announced the acquisition of Callisto, a UK-based consultancy specialising in Regulatory Affairs (RA), Pharmacovigilance (PV) and GMDP services within multiple regulated sectors.
Ardena announced a expansion of its bioanalytical services in the Netherlands, including a new bioanalytical lab at Ardena’s Pivot Park facility in Oss and new GLP capabilities in Assen.
Logical Biological has settled into larger, upgraded laboratory space at Discovery Park, marking its third move within the science and innovation campus.
CluePoints announced that Richard Young has been appointed as its new chief strategy officer who will ensure CluePoints’ continued growth and development as a provider of integrated data review software.
Coronado Research announced that Professor Jennifer Visser-Rogers has been appointed as chief scientific officer, bringing with her a broad portfolio of scientific achievement across academia and industry.
ApiJect announced it has been awarded an initial grant of $425,000 from the Bill & Melinda Gates Foundation to develop low-cost blow-fill-seal prefilled injection devices to enhance access in Low- and Middle-Income Countries (LMICs).
Avantor and NIBRT have formed a new partnership to supply advanced Masterflex equipment, essential products and expert training to foster innovations in biopharma manufacturing.
